Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
  • Nowy
Firestein & Kelley's Textbook of Rheumatology, 2-Volume Set

Firestein & Kelley's Textbook of Rheumatology, 2-Volume Set

9780323935401
2 212,51 zł
1 880,63 zł Zniżka 331,88 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 1 880,63 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
With its comprehensive, global coverage of all aspects of diagnosis, screening, and treatment in both adults and children, Firestein & Kelley’s Textbook of Rheumatology remains your reference of choice in this evolving field. The fully revised 12th Edition retains the user-friendly, full color format, providing in-depth guidance in rheumatology with an ideal balance of basic science and clinical application. New editors, new chapters, and new illustrations keep you fully up to date on recent advances in genetics and the microbiome, current therapies, and other rapid changes in the field.
Szczegóły produktu
Elsevier
102638
9780323935401
9780323935401

Opis

Rok wydania
2024
Numer wydania
12
Oprawa
twarda
Liczba stron
2400
Wymiary (mm)
216 x 276
Waga (g)
450
  • VOLUME I
    1 Developmental Biology, Organization, and Function of the Synovial Joints
    2 Synovium
    3 Cartilage and Chondrocytes
    Development and Biology of Bone
    5 Muscle Anatomy, Physiology, and Biochemistry
    6 Biomechanics
    7 Regenerative Medicine and Tissue Engineering
    8 Proteinases and Matrix Degradation
    9 Dendritic Cells
    10 Mononuclear Phagocytes
    11 Neutrophils
    12 T Lymphocytes
    13 B Cells
    14 Fibroblasts and Fibroblast-like Synoviocytes
    15 Mast Cells and Basophils
    16 Innate Lymphoid Cells and Natural Killer Cells
    17 Platelets and Megakaryocytes
    18 Principles of Signaling
    19 Innate Immunity
    20 Adaptive Immunity
    21 Immune Tolerance and Autoimmunity
    22 Pre-clinical Autoimmunity
    23 The Microbiome in Rheumatic Diseases
    24 Genetics of Rheumatic Diseases
    25 Epigenetics of Rheumatic Diseases
    26 Complement System
    27 Prostaglandins, Leukotrienes, and Related Compounds
    28 Angiogenesis
    29 Cytokines and Chemokines
    30 Neuronal Mechanisms of Pain and Inflammation
    31 Clinical Research Methods in the Rheumatic Diseases
    32 Epidemiology and Impact of Rheumatic Diseases
    33 Assessment of Health Outcomes
    34 Biomarkers in Rheumatology
    35 Occupational, Environmental, and Recreational Musculoskeletal Disorders
    36 Cardiovascular Risk in Inflammatory Rheumatic Disease
    37 Cancer Risk in Rheumatic Diseases
    38 Occupational Therapy, Physical Therapy, and Rehabilitation
    39 General Principles of Pregnancy and Rheumatic Disease: Pre-pregnancy Assessment
    40 History and Physical Examination of the Musculoskeletal System
    41 Ultrasound in Rheumatology
    42 Evaluation of Monoarticular and Polyarticular Arthritis
    43 Skin and Rheumatic Diseases
    44 The Eye and Rheumatic Diseases
    45 Neck Pain
    46 Shoulder Pain
    47 Low Back Pain
    48 Hip and Knee Pain
    49 Foot and Ankle Pain
    50 Hand and Wrist Pain
    51 Temporomandibular Joint Disorders
    52 Fibromyalgia
    53 Synovial Fluid Analyses, Synovial Biopsy, and Synovial Pathology
    54 Arthrocentesis and Injection of Joints and Soft
    Tissues
    55 Anti-nuclear Antibodies
    56 Autoantibodies in Rheumatoid Arthritis
    57 Acute Phase Reactants
    58 Imaging in Rheumatic Diseases
    VOLUME II
    59 Therapeutic Targeting of Prostanoids
    60 Glucocorticoid Therapy
    61 Traditional DMARDs: Methotrexate, Leflunomide, Sulfasalazine, Hydroxychloroquine, and Combination Therapies
    62 Immunosuppressive Drugs
    63 Anti-cytokine Biologics
    64 Cell-Targeted Biologics and Emerging
    Targets: Rituximab, Abatacept, and Other Biologics
    65 Janus Kinase and Other Intra-cellular Targets
    66 Urate-Lowering Therapy
    67 Bisphosphonates
    68 Analgesic Agents in Rheumatic Disease
    69 Nutrition and Rheumatic Diseases
    70 Etiology of Rheumatoid Arthritis
    71 Pathogenesis of Rheumatoid Arthritis
    72 Clinical Features of Rheumatoid Arthritis
    73 Treatment of Rheumatoid Arthritis
    74 Sjögren’s Syndrome
    75 Classification and Epidemiology of Spondyloarthritis
    76 Axial Spondyloarthritis
    77 Reactive Arthritis
    78 Psoriatic Arthritis
    79 Inflammatory Bowel Disease-Associated Arthritis and Other Enteropathic Arthropathies
    80 Etiology and Pathogenesis of Systemic Lupus Erythematosus
    81 Clinical Features of Systemic Lupus Erythematosus
    82 Treatment of Systemic Lupus Erythematosus
    83 Antiphospholipid Syndrome
    84 Etiology and Pathogenesis of Systemic Sclerosis
    85 Clinical Features and Treatment of Scleroderma
    86 Inflammatory Diseases of Muscle and Other Myopathies
    87 Overlap Syndromes
    88 Classification and Epidemiology of Systemic Vasculitis
    89 Giant Cell Arteritis, Polymyalgia Rheumatica, and Takayasu’s Arteritis
    90 Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis
    91 Polyarteritis Nodosa
    92 Immune Complex-Mediated Small Vessel Vasculitis
    93 Primary Central Nervous System Vasculitis
    94 Behçet’s Disease
    95 Pathogenesis of Inflammasome-Mediated Diseases
    96 Etiology and Pathogenesis of Hyperuricemia and Gout
    97 Clinical Features and Treatment of Gout
    98 Calcium Crystal Disease: Calcium Pyrophosphate Deposition Disease and Basic Calcium Phosphate-Associated Syndromes
    99 Familial and Nonfamilial Autoinflammatory Syndromes
    100 Etiology and Pathogenesis of Osteoarthritis
    101 Clinical Features of Osteoarthritis
    102 Treatment of Osteoarthritis
    103 Metabolic Bone Disease
    104 Proliferative Bone Diseases
    105 Osteonecrosis
    106 Relapsing Polychondritis
    107 Heritable Diseases of Connective Tissues
    108 Etiology and Pathogenesis of Juvenile Idiopathic Arthritis
    109 Clinical Features and Treatment of Juvenile Idiopathic Arthritis
    110 Childhood-Onset Systemic Lupus Erythematosus, Drug-Induced Lupus in Children, and Neonatal Lupus
    111 Juvenile Dermatomyositis, Scleroderma, and Vasculitis
    112 Bacterial Arthritis
    113 Lyme Disease
    114 Mycobacterial Infections of Bones and Joints
    115 Fungal Infections of Bones and Joints
    116 Rheumatic Manifestations of Human Immunodeficiency Virus Infection
    117 Viral Arthritis
    118 Rheumatic Fever and Post-streptococcal Arthritis
    119 COVID-19 and Rheumatic Disease
    120 Vaccination in Rheumatic Disease
    121 Amyloidosis
    122 Sarcoidosis
    123 Hemochromatosis
    124 Hemophilic Arthropathy
    125 Rheumatic Manifestations of Hemoglobinopathies
    126 IgG4-Related Disease
    127 Arthritis Accompanying Endocrine and
    128 Rheumatic Paraneoplastic Syndromes and Malignancies With Rheumatic Manifestations
    129 Tumors and Tumor-like Lesions of Joints and Related Structures
    130 Autoimmune Complications of Immune Checkpoint Inhibitors for Cancer
Komentarze (0)

  • Często kupowane razem

    Brak dostępnych produktów